Dovitinib
![]() |
- ₹0
- Product name: Dovitinib
- CAS: 405169-16-6
- MF: C21H21FN6O
- MW: 392.43
- EINECS:1308068-626-2
- MDL Number:MFCD11870802
- Synonyms:4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one;dovitinib;Unii-I35H55G906;CHIR258 7.7G;TKI-258;4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one;CHIR-258(Dovitinib,TKI258);CHIR-258(Dovitinib)
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|
Properties
Density :1.386
storage temp. :-20°
solubility :Soluble in DMSO (up to 30 mg/ml).
form :solid
pka :9.44±0.70(Predicted)
color :Yellow-green
Stability :Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
CAS DataBase Reference :405169-16-6
storage temp. :-20°
solubility :Soluble in DMSO (up to 30 mg/ml).
form :solid
pka :9.44±0.70(Predicted)
color :Yellow-green
Stability :Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
CAS DataBase Reference :405169-16-6
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
Dovitinib is a receptor tyrosine kinase inhibitor that targets vascular endothelial growth factor-2, basic fibroblast growth factor-1, and platelet-derived growth factor β receptors (IC50s = 65, 11, and 5 nM, respectively). By impairing these kinase signals, 1 μM dovitinib has been shown to prevent the growth and motility of pancreatic cancer cell lines (HPAF-II, BxPC-3, MiaPaCa2, and L3.6pl). At 0.04 μM, dovitinib can inhibit endothelial cell proliferation and motility. These antiangiogenic effects have been proposed to be the mechanism by which dovitinib inhibits hepatocellular carcinoma growth and metastasis. Dovitinib has been evaluated in clinical trials for the treatment of advanced solid tumors.More related product prices
Ponatinib BI 2536 Dasatinib Nintedanib Gefitinib AZD-4547 ARRY-334543 Momelotinib CO-1686 PLX3397 (Pexidartinib) CAL-101 Lestaurtinib Masitinib (AB1010) DecernotinibRelated product price
- Dasatinib
₹3702.15-4546.5 - Gefitinib
₹4200-45778.93 - Lestaurtinib
₹18380.85-73458.45
Suppliers and manufacturers
career henan chemical co
A.J Chemicals
Pharmaffiliates Analytics and Synthetics P. Ltd
Pharma Affiliates
ATK CHEMICAL COMPANY LIMITED
BOC Sciences
Chongqing Chemdad Co., Ltd
CONIER CHEM AND PHARMA LIMITED
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tianjin Xinshengjiahe Science & Technology Development Co,.Ltd
₹2.00 /1kg
4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one CAS:405169-16-6
4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one CAS:405169-16-6